• Genexine will issue 1,250,500 common shares through a third-party allotment to raise KRW 3 billion for working capital.
• Korea Quantum AI will purchase the shares at KRW 2,399 each, a 10% discount to the reference price.
• Subscription is scheduled for October 20, 2026, with payment due October 26, 2026.
• The new shares are scheduled to list on November 10, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genexine Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261016000475), on October 16, 2026, and is solely responsible for the information contained therein.